In a nutshell...the PI`s stop the viruus from replcating somewhtt like the RIBA...and the PEG does the killing...BTW...PEG and RIBA were not designed for hepatitis...its just a fluke those drugs work...they wrere initally designed for cancer tx.
"I understand what you are saying, but not fully the mechanism by which HCV can be blocked from reproducing.
I assume there is something in the HCV life cycle that makes it vulnerable"
_________________________
Interferon works in phases. Most of the virus is circulating in your bloodstream. The virus in your blood is the easiest to kill, because it doesn't live as long as the virus that is in liver cells. Also, it is out in the open, so to speak, and not hiding in cells.
The first phase of treatment lasts 1 to 2 days. This phase kills most of the virus circulating in your bloodstream. The action of Interferon in your bloodstream is simple. It mainly slows down the replication of the virus. In order for any life form to survive, it must live long enough to reproduce. By slowing down the rate of replication, the virus dies on its own without producing offspring.
Phase 2 lasts from day 2 through day 14. Interferon is now attacking the virus in your liver cells. This is a slow phase because the virus has trained the liver cells to look as though they aren't infected. The more your viral load drops, the more the interferon is able to see the the infected cells. The Hep C virus has turned the liver cells into virus reproduction factories. It teaches the liver cells how to make more copies of the virus. So now the action of interferon becomes more complicated. Interferon calls for help from other parts of your immune system. These other parts of your immune system degrade the RNA of the virus, interfere with the virus-making process and try to re-teach the liver cells how to behave normally.
Phase 3 lasts from day 14 through day 28, (and continues on through week 24). During this phase, interferon completely switches your immune system into full attack mode. Your immune system can now see which infected liver cells cannot be saved and starts to kill them. Interferon also encourages regeneration of liver cells, so as the infected cells are killed, new cells begin to grow in their place (this is how interferon may help reverse liver damage).
All of this activity takes place within 30 days. That's why your doctor expects to see a 2 log drop in your viral load within 12 weeks of treatment. It means that the interferon is sucessfully working on the virus that is actually in your liver (same with a 4 week RVR).
"I still don't see how the protease inhibitors and SOC can eliminate HCV but not HIV or HBV"
____________________________
The protease of HCV, NS3, is responsible for blocking interferon. That's why protease inhibitors like Telepravir and Boceprevir, are being used for Hep C treatment. They block replication and help interferon.
Co
"Can one not compare the effect of the PIs as making "everybody's" baseline viral load low and making "everybody" a rapid/quicker responder? No slow responders anymore. "
---------------------------------
I suppose you can say that. But the PI's kill the wild type virus (which is the much larger number). You still need the interferon to kill the mutant type virus. And if somebody is interferon resistant, it's not going to work even if the PI lowered the viral load.
Co
"The virus in your blood is the easiest to kill, because it doesn't live as long as the virus that is in liver cells."
Is this true? I thought an HCV copy was extremely short lived anyway. But that blood cells regenerate in 4 weeks, whereas liver cells regenerate in 300-500 days.
Do you have a link to what you stated in your post? It would be interesting to read the original link.
With all due respect.... we may have to re-define what we mean when we call people "non-responders". It appears that non-responders do indeed respond to Telaprevir triple therapy . Willy
-------------------------------------------------------------------
http://www.hivandhepatitis.com/2008icr/aasld/docs/111108_a.html
Prove 3 results reported at AASLD 2008 (from 453 genotype 1 ----past TX failures)
"Based on these findings, the investigators stated, "In a population of patients who have failed previous [pegylated interferon/ribavirin] treatment, response rates 12 weeks after end of treatment were 52% overall in the T12/PR 24 arm: 73% in prior relapsers, 41% in prior non-responders."
(These were SVR 12 results and therefore not "official"-- Willy)
Non-responders does not tell us if we can do without response to SOC. Null responders does.